comparemela.com

Latest Breaking News On - Enveric biosciences - Page 5 : comparemela.com

Enveric Biosciences, Inc (NASDAQ:ENVB) Short Interest Update

Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 150,400 shares, a growth of 58.1% from the February 29th total of 95,100 shares. Approximately 3.2% of the company’s shares are sold short. […]

Enveric biosciencesAdvisorshares investmentsArmistice capitalMillennium managementVirtu financialRenaissance technologiesEnveric biosciences company profileEnveric biosciences incGet free reportShares investmentsEnveric biosciences daily

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023

Product Development Highlights: Selected neuroplastogen lead candidate EB-003, a potential first-in-class therapeutic option for addressing difficult-to-treat mental health disorders by promoting.

United kingdomUnited statesEnveric biosciencesJoseph tuckerBusiness developmentTrademark officeAmerican chemical societyExchange commissionNeuropsychiatric drug development summitCanadian chemical engineering conferenceMedicinal chemistryOut licensing opportunitiesUnited states patentAnnual reportQuarterly reports

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets

Patents extend compositional protection to proprietary compounds .

United statesUnited kingdomJoseph tuckerEnveric biosciencesExchange commissionTrademark officeCompany psybraryUnited states patentSubstituent psilocybinNon binding term sheetsNew chemical entitiesAnnual reportQuarterly reports

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds - Enveric Biosciences (NASDAQ:ENVB)

Joseph tuckerEnveric biosciencesInvestigational new drug

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomEnveric biosciencesJoseph tuckerCasey mcdonaldDaniel kontoh boatengCompany psybraryExchange commissionNew chemical entitiesAnnual reportQuarterly reports

vimarsana © 2020. All Rights Reserved.